Study of a Simplified Geriatric Evaluation Performed by Oncologists Prior to Cancer Treatment by Radiotherapy or Chemotherapy in Subjects Aged 70 Years or Older With Inoperable Squamous Cell Cancer of the Head and Neck

• Conditions: Inoperable Squamous Cell Cancer of the Head and Neck
• Interventions: Other: Geriatric Screening Test G8; Other: Geriatric fragility test GERICO

• Registration Number: NCT03614936
• Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Brief Summary

Use by Oncologists of Validated Geriatric Assessment Tools: G8 Screening Test and Certain Tests for Thorough Geriatric Evaluation

Detailed Description

Not available

Study Timeline

• Study Start: 2013-06-11
• Status Verified: 2018-07
• Study First Submitted: 2018-07-30
• Study First Submitted QC: 2018-07-30
• Last Update Submitted: 2018-07-30
• Study First Posted: 2018-08-03
• Last Update Posted: 2018-08-03
• Primary Completion: 2019-06
• Study Completion: 2019-06

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 800

Inclusion Criteria

• Subject aged 70 or over
• Carrier of squamous cell carcinoma of the head and neck, locally advanced undergoing treatment by radiotherapy or metastatic / recurrence not accessible to treatment curative locoregional under treatment with chemotherapy.
• Patient likely to be eligible for ELAN-RT or ELAN-FIT or ELAN-UNFIT trials.
• Patients affiliated to a social security scheme

Exclusion Criteria

• Person deprived of liberty or under guardianship,
• Presence of a neuro-psychological condition, family, social, or geographical, which may hinder the smooth running of the study.
• Patient expressing opposition to participation in this study

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Inoperable squamous cell cancer of the head and neck	Geriatric fragility test GERICO	patients 70 years of age or older with ENT carcinoma
Inoperable squamous cell cancer of the head and neck	Geriatric Screening Test G8	patients 70 years of age or older with ENT carcinoma

Primary Outcome Measures

Name	Time	Method
Completion rate	Up to 1 year	Rate of completion of each of the geriatric fragility test questionnaires and the G8 questionnaire and duration of the geriatric evaluation performed by the oncologist

Trial Locations

Locations (1)

Gustave Roussy; 🇫🇷 Villejuif, Val De Marne, France